Yangzhou Huitong Technology Corp.,
301601
Scantech
688583
MEIDENG TECHNOLOGY
838227
Hangzhou Onechance Tech Corp.
300792
Jiangsu Zhengdan Chemical Industry
300641
CN Stock MarketDetailed Quotes
300966 Hubei Goto Biopharm
- 15.47
- -0.03-0.19%
Trading Jan 15 09:48 CST
1.78BMarket Cap-127.85P/E (TTM)
15.66High15.29Low2.50KlotVolume15.66Open15.50Pre Close3.85MTurnover0.33%Turnover Ratio77.35P/E (Static)115.28MShares23.7852wk High2.12P/B1.16BFloat Cap12.0152wk Low18.60Limit Up75.13MShs Float79.83Historical High12.40Limit Down2.39%Amplitude12.01Historical Low0.02Dividend TTM15.41Avg Price1.16KlotAsk0.10%Div YieldTTM100Lot Size1.22KlotBid
Hubei Goto Biopharm Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -5.98%130.49M | 86.89%304.3M | -58.08%116.79M | -58.49%181.97M | -40.61%138.79M | -64.21%162.82M | 39.07%278.61M | 108.86%438.42M | 90.27%233.68M | 163.55%454.89M |
| Transactional financial assets | --1.01K | --1.01K | -99.99%1.01K | -99.99%1.01K | ---- | ---- | 9,735.38%10M | 14,736.44%15.01M | ---- | ---- |
| Notes receivable and accounts receivable | 6.07%202.19M | -10.14%212.7M | -6.45%218.63M | -4.00%219.7M | -26.03%190.62M | 4.04%236.71M | 7.97%233.7M | 4.10%228.86M | -9.83%257.69M | -18.23%227.51M |
| -Notes receivable | 53.30%21.65M | -48.07%16.02M | -84.84%6.25M | -83.04%9.5M | -68.74%14.12M | 109.71%30.85M | 65.02%41.22M | 57.39%56.01M | 17.72%45.17M | -71.43%14.71M |
| -Accounts receivable | 2.29%180.54M | -4.46%196.68M | 10.33%212.38M | 21.61%210.2M | -16.95%176.5M | -3.26%205.86M | 0.53%192.48M | -6.19%172.85M | -14.11%212.52M | -6.15%212.8M |
| Other receivables (including interest and dividends) | 20.57%2.85M | 20.65%2.53M | 26.11%2.49M | 13.98%2.15M | -6.66%2.36M | -35.60%2.09M | -60.89%1.98M | -9.85%1.88M | 9.24%2.53M | 29.37%3.25M |
| -Other receivable | ---- | 20.65%2.53M | ---- | ---- | ---- | -35.60%2.09M | ---- | -9.85%1.88M | ---- | 29.37%3.25M |
| Advance payment | 287.80%21.85M | 413.99%22.49M | 284.79%28.12M | -45.24%19.8M | -40.21%5.63M | -56.97%4.37M | -55.59%7.31M | 110.80%36.15M | -70.66%9.42M | -53.12%10.17M |
| Inventories | -13.18%383.82M | -14.58%389.56M | -21.96%370.73M | -8.40%396.16M | 3.75%442.1M | 8.50%456.06M | 17.18%475.05M | 16.50%432.5M | 62.69%426.12M | 69.53%420.33M |
| Receivable financing | -85.05%7.83M | -69.25%16.62M | -59.36%9.21M | -61.25%15.69M | 34.74%52.39M | 28.89%54.07M | -40.83%22.65M | 68.69%40.5M | -3.26%38.88M | -5.22%41.95M |
| Other current assets | -49.82%9.29M | 118.90%35.19M | -21.37%26.73M | 67.90%34.26M | 89.83%18.52M | 56.22%16.08M | 303.43%33.99M | 46.80%20.4M | 95.43%9.76M | 12.44%10.29M |
| Total current assets | -10.83%758.32M | 5.49%983.39M | -27.33%772.7M | -28.34%869.73M | -13.05%850.42M | -20.21%932.2M | 19.40%1.06B | 41.42%1.21B | 30.37%978.09M | 50.47%1.17B |
| Non Current assets | ||||||||||
| Investment real estate | -3.35%18.17M | -3.32%18.33M | -3.89%18.49M | --18.64M | --18.8M | --18.96M | --19.24M | ---- | ---- | ---- |
| Long-term equity investment | 1.34%48.55M | 1.00%48.49M | 0.08%48.12M | 0.32%48.24M | -0.47%47.91M | 66.02%48.01M | 66.43%48.08M | 232.24%48.08M | 234.26%48.14M | 100.82%28.92M |
| Fixed assets | ---- | 171.59%516.61M | ---- | ---- | ---- | 6.96%190.22M | ---- | 6.07%192.66M | ---- | -4.27%177.85M |
| Fixed assets liquidation | ---- | 72.84%1.09M | ---- | ---- | ---- | --628.19K | ---- | -46.99%628.19K | ---- | ---- |
| Constru in process | ---- | 52.15%1.01B | ---- | ---- | ---- | 247.77%664.3M | ---- | 503.88%398.65M | ---- | 7,252.97%191.02M |
| Construction materials | ---- | 77.13%45.9M | ---- | ---- | ---- | 18.63%25.91M | ---- | 3,553.78%13.33M | ---- | 4,715.10%21.84M |
| Intangible assets | 87.66%50.16M | 87.61%50.44M | 88.10%50.72M | 18.21%51M | -2.28%26.73M | -2.27%26.89M | -2.54%26.96M | 55.06%43.14M | -2.23%27.35M | -2.29%27.51M |
| Long deferred expense | -9.53%10.21M | -4.49%11.3M | -5.51%11.84M | -4.29%12.65M | -14.40%11.29M | 535.32%11.83M | 6,163.96%12.53M | 6,509.34%13.22M | --13.19M | --1.86M |
| Deferred tax assets | 48.03%33.83M | 31.29%28.4M | 20.47%23.55M | 26.42%22.62M | 167.28%22.86M | 155.08%21.63M | 135.16%19.55M | 102.84%17.89M | 88.29%8.55M | 113.79%8.48M |
| Usufruct assets | -93.70%85.05K | -98.16%99.23K | -81.07%1.09M | -80.80%1.21M | -80.12%1.35M | -27.60%5.39M | -27.93%5.77M | -26.37%6.3M | -25.36%6.79M | 414.21%7.45M |
| Other non current assets | -63.20%63.28M | -64.01%57.74M | -80.51%28.62M | -72.89%32.98M | 32.57%171.97M | 73.28%160.42M | 78.29%146.83M | 177.04%121.67M | 104.64%129.72M | 192.64%92.58M |
| Total non current assets | 42.05%1.94B | 52.37%1.79B | 68.30%1.71B | 84.44%1.58B | 88.84%1.37B | 110.61%1.17B | 130.26%1.01B | 142.38%855.57M | 136.86%722.85M | 107.69%557.51M |
| Total assets | 21.75%2.7B | 31.62%2.77B | 19.34%2.48B | 18.29%2.45B | 30.25%2.22B | 22.05%2.11B | 56.07%2.08B | 70.84%2.07B | 61.16%1.7B | 65.17%1.73B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 93.93%252.27M | 47.55%236.27M | -11.42%177.16M | -65.77%110.09M | -60.32%130.09M | -48.05%160.13M | -12.30%200M | 124.27%321.63M | 173.22%327.86M | 113.01%308.24M |
| Notes payable and accounts payable | 32.90%477.99M | 96.81%510.12M | 167.15%501.95M | 158.97%532.24M | 128.94%359.65M | 14.91%259.19M | 25.05%187.89M | 48.74%205.52M | 106.01%157.1M | 269.62%225.56M |
| -Notes payable | -48.79%71.47M | 221.13%89.37M | 515.70%124.41M | 299.94%216.81M | 268.90%139.58M | -52.16%27.83M | -60.69%20.21M | -4.68%54.21M | -12.53%37.84M | 456.60%58.17M |
| -Accounts payable | 84.72%406.51M | 81.85%420.75M | 125.15%377.54M | 108.46%315.42M | 84.53%220.08M | 38.21%231.37M | 69.62%167.68M | 86.12%151.31M | 261.41%119.26M | 230.99%167.4M |
| Contract liabilities | -28.73%1.19M | -56.36%806.79K | -45.69%1.14M | 523.68%3.47M | 28.20%1.67M | 114.46%1.85M | 23.44%2.1M | -84.95%556.2K | -43.36%1.3M | -81.14%862.05K |
| Advance receipts | 0.68%212.7K | 0.63%354.5K | --496.29K | --45.29K | --211.27K | --352.29K | ---- | ---- | ---- | ---- |
| Salaries payable | 19.28%5.25M | 0.26%4.69M | 24.93%5.32M | -16.31%7.4M | 31.69%4.4M | 52.01%4.68M | 59.95%4.26M | 25.44%8.85M | 51.88%3.34M | -7.23%3.08M |
| Taxs payable | -28.92%2.84M | -51.42%874.85K | -70.62%2.1M | -45.43%4.08M | -32.14%3.99M | -44.96%1.8M | -29.43%7.14M | -34.36%7.49M | -28.11%5.88M | -57.28%3.27M |
| Other payable (including interest and dividends) | -58.08%796.83K | -62.74%700.38K | -80.06%633.71K | -20.67%1.64M | 49.61%1.9M | 122.53%1.88M | 736.04%3.18M | 398.09%2.07M | 136.18%1.27M | 82.02%844.73K |
| -Interest payable | ---- | ---- | ---- | ---- | ---- | ---- | 341.22%863.17K | ---- | 395.09%487.11K | 70.88%217.37K |
| -Other payable | ---- | -62.74%700.38K | ---- | ---- | ---- | 199.63%1.88M | ---- | 552.78%2.07M | ---- | 86.23%627.36K |
| Non current liabilities due within one year | 20.14%21.44M | 43.39%25.93M | 201.05%20.33M | 214.79%22.72M | 1,214.01%17.85M | 901.60%18.08M | -11.53%6.75M | -37.04%7.22M | -91.22%1.36M | -89.26%1.81M |
| Other current liabilities | 110.78%20M | 49.52%29.13M | -90.71%2.99M | -79.19%4.71M | -4.75%9.49M | 268.06%19.48M | 670.33%32.19M | 28.88%22.64M | -64.89%9.96M | -75.50%5.29M |
| Total current liabilities | 47.75%782M | 73.04%808.88M | 60.57%712.13M | 19.17%686.41M | 4.17%529.26M | -14.85%467.46M | 9.52%443.51M | 72.87%575.97M | 100.56%508.08M | 111.00%548.96M |
| Current liabilities | ||||||||||
| Long term loan | 33.63%420.96M | 83.23%502.08M | 15.81%334.12M | 121.17%349.72M | 35.03%315.02M | 17.45%274.02M | 1,342.49%288.5M | --158.12M | --233.3M | --233.3M |
| Bonds payable | 8.38%321.45M | 8.43%315.14M | 8.43%308.9M | 8.51%302.66M | --296.6M | --290.64M | --284.89M | --278.92M | ---- | ---- |
| Estimate liabilities | --0 | --30K | --30K | -39.18%30K | ---- | ---- | ---- | --49.33K | ---- | ---- |
| Deferred tax liabilities | -96.05%12.76K | -98.81%14.88K | -80.99%257.3K | -70.22%289.42K | --322.67K | --1.25M | 497,981.42%1.35M | 505,049.38%971.86K | ---- | ---- |
| Long term deferred income | 104.72%141.39M | 52.28%105.5M | 37.43%95.5M | 20.98%84.33M | -0.38%69.06M | -0.38%69.28M | 62.49%69.49M | 62.18%69.71M | 830.19%69.33M | 846.50%69.54M |
| Lease liabilities | --0 | --0 | -89.68%451.44K | -87.80%538.63K | -98.47%87.35K | -13.40%4.57M | -21.77%4.37M | -33.78%4.41M | -15.95%5.71M | 380.06%5.28M |
| Total non current liabilities | 29.76%883.81M | 44.23%922.75M | 13.98%739.26M | 44.00%737.56M | 120.89%681.09M | 107.63%639.76M | 848.81%648.61M | 931.65%512.18M | 2,065.10%308.34M | 3,021.19%308.13M |
| Total liabilities | 37.63%1.67B | 56.40%1.73B | 32.90%1.45B | 30.86%1.42B | 48.25%1.21B | 29.18%1.11B | 130.73%1.09B | 184.24%1.09B | 205.12%816.42M | 217.39%857.09M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%115.28M | 0.00%115.28M | 0.00%115.28M | 0.00%115.28M | 0.00%115.28M | 0.00%115.28M | 0.00%115.28M | 0.00%115.28M | 0.00%115.28M | 0.00%115.28M |
| Other equity instruments | -0.01%96.49M | -0.01%96.49M | -0.01%96.49M | -0.01%96.49M | --96.5M | --96.5M | --96.51M | --96.51M | ---- | ---- |
| Capital reserve funds | 0.19%412.26M | 0.40%412.02M | 0.54%411.3M | 0.41%410.77M | 0.58%411.47M | 0.32%410.4M | 0.00%409.11M | 0.00%409.11M | 0.00%409.11M | 0.00%409.11M |
| Surplus reserve funds | 0.00%9.86M | 0.00%9.86M | 0.00%9.86M | 0.00%9.86M | 0.00%9.86M | 0.00%9.86M | 0.00%9.86M | 0.00%9.86M | 41.27%9.86M | 41.27%9.86M |
| Retained profit | -4.93%304.34M | -0.45%313.38M | 7.48%323.89M | 7.74%320.34M | 7.77%320.12M | 10.81%314.81M | 5.42%301.34M | 8.99%297.34M | 18.15%297.05M | 19.17%284.11M |
| Shareholders equity without minority interests | -1.57%938.23M | 0.02%947.03M | 2.65%956.83M | 2.66%952.75M | 14.67%953.24M | 15.70%946.85M | 13.66%932.09M | 15.00%928.09M | 6.20%831.29M | 6.31%818.36M |
| Minority interests | 79.81%93.21M | 79.28%93.81M | 33.54%70.37M | 33.83%71.03M | -2.60%51.84M | 3.72%52.33M | 41.30%52.7M | 148.43%53.07M | 950.18%53.23M | 887.61%50.45M |
| Total shareholder equity | 2.62%1.03B | 4.17%1.04B | 4.31%1.03B | 4.34%1.02B | 13.63%1.01B | 15.01%999.18M | 14.86%984.79M | 18.44%981.16M | 12.27%884.52M | 12.12%868.81M |
| Total liabilityies and equity | 21.75%2.7B | 31.62%2.77B | 19.34%2.48B | 18.29%2.45B | 30.25%2.22B | 22.05%2.11B | 56.07%2.08B | 70.84%2.07B | 61.16%1.7B | 65.17%1.73B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.